Prostate Cancer Clinical Trial

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Summary

The purpose of this study is to test two different ways to help men with sexual rehabilitation.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

As per medical record, early stage prostate cancer (Pathologic Stage 1/2 with Gleason score As per medical record, radical prostatectomy (RP) conducted either at MSKCC or at another institution
As per medical record, ≤ 9 months post-RP
As per medical record, moderate erectile functioning pre-surgery (i.e., 15 or greater on the IIEF Erectile Function Domain (EFD) score, or graded their erections as a 1 or 2 on the standard 5 point Urology Erectile Function scale, or have a score of 6 or greater on the 1-10 pre-surgery erectile function scale on the SMRP assessment or have a total score of 15 or greater on items 2-7 on the Prostrate Quality of Life Survey: Sexual Domain)
As per self report or as per medical record starting penile injections as part of the erectile rehabilitation program at MSKCC
In the judgment of the consenting professional able to communicate, comprehend, and complete questionnaires in English

Exclusion Criteria:

Both cavernous nerves fully resected as per surgery report (nerve sparing score of 8 in MSKCC surgeon note), or documented in the progress note that the nerves were fully resected.
Currently on or has a history of being an Androgen Deprivation Therapy (ADT)
Has any indication of Prostate-Specific Antigen (PSA)
As per self report, specific injection phobia
In the judgment of the consenting professional is unable to provide informed consent and complete study sessions and assessment.
As per self report or as documented in the medical record, current untreated (e.g. no medication no therapy) major psychiatric disorder (schizophrenia, major depression). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

224

Study ID:

NCT02706561

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Christian Nelson, PhD
Contact
646-888-0030
Andrew Roth, MD
Contact
646-888-0024
Christian Nelson, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

224

Study ID:

NCT02706561

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.